Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation.
Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude.
Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis.
Optical Coherence Tomography for the Radiologist.
Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis.
The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.
Multiple sclerosis and seizures: incidence and prevalence over 40 years.
Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.
Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.
Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.
Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis.
Identifying and treating pain caused by MS.
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone.
Oligodendrocyte-Specific Activation of PERK Signaling Protects Mice against Experimental Autoimmune Encephalomyelitis.
HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients.
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.
Disease mechanisms in MS: A role for sodium channels in regulation of macrophage-mediated pathology in multiple sclerosis lesions.
Management of optic neuritis as a clinically first event of multiple sclerosis.
Uveitis as a prognostic factor in multiple sclerosis.
A Comparison of Supervised Machine Learning Algorithms and Feature Vectors for MS Lesion Segmentation Using Multimodal Structural MRI.
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.
The Bioenergetic Health Index: a new concept in mitochondrial translational research.

Pages